KM Financial Solutions | UPDATE 3-U.S. to consider expanding Medicare drug price negotiation
17065
post-template-default,single,single-post,postid-17065,single-format-standard,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,hide_top_bar_on_mobile_header,qode-child-theme-ver-1.0.0,qode-theme-ver-11.2,qode-theme-bridge,wpb-js-composer js-comp-ver-5.2.1,vc_responsive
 

UPDATE 3-U.S. to consider expanding Medicare drug price negotiation

UPDATE 3-U.S. to consider expanding Medicare drug price negotiation

WASHINGTON/NEW YORK, May 14 (Reuters) – The Trump
administration is considering expanding Medicare’s ability to
negotiate the cost of drugs by giving private payers a role in
setting the price of medicines administered in hospitals and
doctors’ offices, Health and Human Services Secretary Alex Azar
said on Monday.

No Comments

Sorry, the comment form is closed at this time.